Mark Andrew Wilson, Chief Legal Officer: Nektar Therapeutics NKTR Sell · Filed 25/08/21

Trade details

Type: Insider sale
Amount: $17,974.84
Shares · price: 676 sh · $26.59 a share
Held after: 20,312 sh
Stock: Nektar Therapeutics NKTR
Person: Mark Andrew WilsonChief Legal Officer
Trade date: 25/08/19
Filed: 25/08/21
Days to filing: 2 days

Sold 3.2% of holdings

Share of holding sold: 3.2%

Nektar Therapeutics trades, last 26 weeks

What else happened in Nektar Therapeutics around then

Filed or reported within 30 days of the trade day · 25/07/20~25/09/18

Mark Andrew Wilson's recent trades

Mark Andrew WilsonFormer Officer
Planned saleNektar Therapeutics
Planned sale
Nektar Therapeutics
NKTR
$5.7M
78,510 sh
$5.7M
Filed 03/13
Traded 03/13
Mark Andrew WilsonChief Legal Officer
SellNektar Therapeutics
Sell
Nektar Therapeutics
NKTR
$34.2K
630 sh
$34.2K
Filed 25/11/25
Traded 25/11/25
Mark Andrew WilsonOfficer
Planned saleNektar Therapeutics
Planned sale
Nektar Therapeutics
NKTR
$37.1K
630 sh
$37.1K
Filed 25/11/25
Traded 25/11/25
Mark Andrew WilsonOfficer
Planned saleNektar Therapeutics
Planned sale
Nektar Therapeutics
NKTR
$18K
676 sh
$18K
Filed 25/08/19
Traded 25/08/19
Mark Andrew WilsonChief Legal Officer
SellNektar Therapeutics
Sell
Nektar Therapeutics
NKTR
$6,697
9,996 sh
$6,697
Filed 25/05/21
Traded 25/05/19